Zennova Pharmaceuticals Group
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zennova Pharmaceuticals Group - overview
Established
2018
Location
Chengdu, Sichuan, China
Primary Industry
Biotechnology
About
Based in Chengdu, China, and founded in 2018. Zennova Pharmaceuticals Group is a pharmaceutical company that focuses on the R&D, manufacturing, and sales of new drugs. The company has research and development, and production bases in Chengdu, and USA. The Chengdu production base passed the certifications, such as US FDA, EU EMA, and China cGMP standards.
Dahai Guo, The company's chairman of the board and chief executive officer, has served as chairman and CEO over 7 companies, such as PuraCap pharceutical LLC, Humanwell USA LLC. In July 2023, Zennova Pharmaceuticals Group raised approximately CNY 100 million in series B funding from new investor HBM Protections. The company provides ophthalmic drugs, antitumor drugs, antiviral drugs, and cardiovascular drugs. It has technology platform, Liquipuls, integrates with Pulsed Microdialysis (PMD) analysis, microsphere coating, slow and controlled release, nanoparticle technology, optimised delivery technology.
Its products are sold to American, Europe, Japan and Southeast Asia. The company will complete the production base's interior decoration and equipment installation in September 2023, and start the technical transfer of the FDA-approved series of drugs in the fourth quarter.
Current Investors
DYEE Capital, E-town Sun Fund, Sichuan Venture Capital
Primary Industry
Biotechnology
Sub Industries
Bioinformatics, Healthcare IT, Oncology/Cancer Treatment, Cardiology, Optometrists & Opticians Products and Services, Pharmaceutical Research & Development
Website
www.zennova.com
Verticals
HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.